278 related articles for article (PubMed ID: 15915364)
1. Blastocystis hominis and the evaluation of efficacy of metronidazole and trimethoprim/sulfamethoxazole.
Moghaddam DD; Ghadirian E; Azami M
Parasitol Res; 2005 Jun; 96(4):273-5. PubMed ID: 15915364
[TBL] [Abstract][Full Text] [Related]
2. Effect of trimethoprim-sulfamethaxazole in Blastocystis hominis infection.
Ok UZ; Girginkardeşler N; Balcioğlu C; Ertan P; Pirildar T; Kilimcioğlu AA
Am J Gastroenterol; 1999 Nov; 94(11):3245-7. PubMed ID: 10566723
[TBL] [Abstract][Full Text] [Related]
3. No advantage for antibiotic treatment over placebo in Blastocystis hominis-positive children with recurrent abdominal pain.
Heyland K; Friedt M; Buehr P; Braegger CP
J Pediatr Gastroenterol Nutr; 2012 May; 54(5):677-9. PubMed ID: 22002479
[TBL] [Abstract][Full Text] [Related]
4. Pathogenicity of Blastocystis hominis, a clinical reevaluation.
Kaya S; Cetin ES; Aridoğan BC; Arikan S; Demirci M
Turkiye Parazitol Derg; 2007; 31(3):184-7. PubMed ID: 17918055
[TBL] [Abstract][Full Text] [Related]
5. [The effect of trimethoprim-sulfamethoxazole in Blastocystis hominis infection].
Ertuğ S; Dost T; Ertabaklar H; Gültekin B
Turkiye Parazitol Derg; 2009; 33(4):270-2. PubMed ID: 20101575
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy of Saccharomyces boulardii or metronidazole in symptomatic children with Blastocystis hominis infection.
Dinleyici EC; Eren M; Dogan N; Reyhanioglu S; Yargic ZA; Vandenplas Y
Parasitol Res; 2011 Mar; 108(3):541-5. PubMed ID: 20922415
[TBL] [Abstract][Full Text] [Related]
7. Low efficacy of metronidazole in the eradication of Blastocystis hominis in symptomatic patients: Case series and systematic literature review.
Batista L; Pérez Jove J; Rosinach M; Gonzalo V; Sainz E; Loras C; Forné M; Esteve M; Fernández-Bañares F
Gastroenterol Hepatol; 2017; 40(6):381-387. PubMed ID: 28279442
[TBL] [Abstract][Full Text] [Related]
8. A placebo-controlled treatment trial of Blastocystis hominis infection with metronidazole.
Nigro L; Larocca L; Massarelli L; Patamia I; Minniti S; Palermo F; Cacopardo B
J Travel Med; 2003; 10(2):128-30. PubMed ID: 12650658
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic infection with Blastocystis sp. subtype 8 successfully treated with trimethoprim-sulfamethoxazole.
Stensvold CR; Arendrup MC; Nielsen HV; Bada A; Thorsen S
Ann Trop Med Parasitol; 2008 Apr; 102(3):271-4. PubMed ID: 18348782
[No Abstract] [Full Text] [Related]
10. Isolate resistance of Blastocystis hominis to metronidazole.
Haresh K; Suresh K; Khairul Anus A; Saminathan S
Trop Med Int Health; 1999 Apr; 4(4):274-7. PubMed ID: 10357863
[TBL] [Abstract][Full Text] [Related]
11. Eradication of Blastocystis hominis prevents the development of symptomatic Hashimoto's thyroiditis: a case report.
Rajič B; Arapović J; Raguž K; Bošković M; Babić SM; Maslać S
J Infect Dev Ctries; 2015 Jul; 9(7):788-91. PubMed ID: 26230132
[TBL] [Abstract][Full Text] [Related]
12. Blastocystis hominis--an emerging cause of diarrhoea in renal transplant recipients.
Rao K; Sekar U; Iraivan KT; Abraham G; Soundararajan P
J Assoc Physicians India; 2003 Jul; 51():719-21. PubMed ID: 14621046
[TBL] [Abstract][Full Text] [Related]
13. IN VIVO AND IN VITRO EFFICACY OF NIGELLA SATIVA AQUEOUS EXTRACT ON BLASTOCYSTIS HOMINIS.
Eida OM; El-Shafei HA; Nomeir YA; El Safhi MB
J Egypt Soc Parasitol; 2016 Apr; 46(1):27-34. PubMed ID: 27363038
[TBL] [Abstract][Full Text] [Related]
14. [Blastocystis hominis and abdominal pain in childhood].
Fleta Zaragozano J; Clavel Parrilla A; Castillo García FJ; Bueno Lozano M; Sarría Chueca A
An Esp Pediatr; 1993 Jan; 38(1):13-6. PubMed ID: 8439071
[TBL] [Abstract][Full Text] [Related]
15. [Blastocystis--an enigmatic parasite].
Stensvold CR; Arendrup MC; Nielsen HV; Mølbak K
Ugeskr Laeger; 2009 Aug; 171(34):2388-90. PubMed ID: 19732521
[TBL] [Abstract][Full Text] [Related]
16. Blastocystis hominis in hospital employees.
Grossman I; Weiss LM; Simon D; Tanowitz HB; Wittner M
Am J Gastroenterol; 1992 Jun; 87(6):729-32. PubMed ID: 1590309
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of Blastocystis hominis isolated from patients with irritable bowel syndrome.
Yakoob J; Jafri W; Jafri N; Islam M; Asim Beg M
Br J Biomed Sci; 2004; 61(2):75-7. PubMed ID: 15250669
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the in vitro effect of Nigella sativa aqueous extract on Blastocystis hominis isolates.
El Wakil SS
J Egypt Soc Parasitol; 2007 Dec; 37(3):801-13. PubMed ID: 18383782
[TBL] [Abstract][Full Text] [Related]
19. In Vitro Antimicrobial Susceptibility Patterns of Blastocystis.
Roberts T; Bush S; Ellis J; Harkness J; Stark D
Antimicrob Agents Chemother; 2015 Aug; 59(8):4417-23. PubMed ID: 25987633
[TBL] [Abstract][Full Text] [Related]
20. [Frequency and in vitro susceptibility antiparasitic of Blastocystis hominis from patients admitted to the Hospital Regional Lambayeque, Peru].
Silva-Díaz H; Flores-Esqueche L; Llatas-Cancino D; Guevara Vásquez G; Silva-García T
Rev Gastroenterol Peru; 2016; 36(3):197-202. PubMed ID: 27716755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
